Clinical study of congenital central hypoventilation syndrome in four cases
10.3760/cma.j.issn.1673-4912.2013.06.017
- VernacularTitle:先天性中枢性低通气综合征四例临床研究
- Author:
Tao HAN
;
Yaling DENG
;
Yao YANG
;
Qiupine LI
;
Jing LIANG
;
Changshuan YANG
;
Xiaojuan YIN
- Publication Type:Journal Article
- Keywords:
Congenital central hypoventilation syndrome;
Genetic testing;
Non-invasive ventilation;
Newborn
- From:
Chinese Pediatric Emergency Medicine
2013;20(6):606-609
- CountryChina
- Language:Chinese
-
Abstract:
Objective This study aimed to explore the clinical characteristics and treatment of congenital central hypoventilation syndrome(CCHS),to raise awareness on the CCHS for early diagnosis and treatment.Methods The clinical data of 4 babies with CCHS were analyzed,all of the babies were repeated bruising,hypercapnia,and difficult-to-wean.After the relevant checks,we precluded the primary diseases of heart,lung and neuromuscular dysfunction that lead to low ventilation,and detected the major pathogenic genes,Phox2b of CCHS,refer to literature and diagnostic criteria of CCHS.Results Four babies all had typical clinical features of CCHS:enough ventilation when awake.But when they were asleep,their respiratory rate slowed down,hypoventilation,cyanosis and hypercapnia appeared,and they can not be awaked by hypercapnia and hypoxemia caused by hypoventilation.Genetic testing confirmed the presence of Phox2b mutations.Two infants were supported by non-invasive biphasic positive airway pressure(BiPAP),an infant was discharged home at 3 months of age with non-invasive BiPAP,and an infant was discharged home at 1 month of age.Both of them were monitored and treated at home,and showed normal development.Conclusion For babies who were repeated bruising,hypercapnia,and difficult-to-wean,but no primary diseases of heart,lung and neuromuscular dysfunction that lead to low ventilation,CCHS must be considered.Genetic testing of Phox2b can be used as an important diagnostic tool,and non-invasive BiPAP is one of the efficacious methods in the treatment of CCHS.
